We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 01, 2020

Comparison of Treatment-Related AEs of Different CDK4/6 Inhibitors in Metastatic Breast Cancer

Cancer Treatment Reviews


Additional Info

Cancer Treatment Reviews
Comparison of Treatment-Related Adverse Events of Different Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer: A Network Meta-analysis
Cancer Treat. Rev 2020 Aug 17;90(xx)102086, A Desnoyers, MB Nadler, V Kumar, R Saleh, E Amir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading